💊
Copiktra
duvelisib
Leukemia, Lymphocytic, Chronic, B-Cell;Lymphoma, Follicular
🚫 Withdrawn
✅
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Copiktra monotherapy is indicated for the treatment of adult patients with: Relapsed or refractory chronic lymphocytic leukaemia (CLL) after at least two prior therapies. Follicular lymphoma (FL) that is refractory to at least two prior systemic therapies.
⚠️ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/copiktra